Resistance to antiplatelet drugs: is it real or relevant?
Berger
Peter B
PB
Division of Cardiovascular Diseases, Duke University Medical Center, Durham, North Carolina, USA.
D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D019917:Blood Vessel Prosthesis Implantation; D001918:Brachytherapy; D000077144:Clopidogrel; D023921:Coronary Stenosis / Q000628:therapy; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D004351:Drug Resistance / Q000187:drug effects; D006083:Graft Occlusion, Vascular / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin